| Revenue growth | Value |
|---|---|
| 1Y (TTM) | +5% |
| 3Y CAGR | +11% |
| Profit growth | Value |
|---|---|
| 1Y (TTM) | +9% |
| 3Y CAGR | +7.0% |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
PfizerPFIZER | ₹4,703.80 -36.60 (0.77%) | 21,500.75 | 29.25 | 5.12 | ||
Caplin Point LaboratoriesCAPLIPOINT | ₹2,517.20 -23.50 (0.92%) | 19,125.30 | 28.21 | 5.33 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹7,106.50 -29.50 (0.41%) | 17,765.63 | 104.73 | 20.35 | ||
Natco PharmaNATCOPHARM | ₹853.80 -3.80 (0.44%) | 15,284.34 | 13.35 | 1.66 |